Mesalamine Delayed-release Tablets

Mesalamine Delayed-release Tablets
SPL v7
SPL
SPL Set ID 29c0dd58-d2cf-40fa-bc32-0eab61937331
Route
ORAL
Published
Effective Date 2022-10-21
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Mesalamine (1.2 g)
Inactive Ingredients
Carboxymethylcellulose Sodium Cellulose, Microcrystalline Ferric Oxide Red Ferric Oxide Yellow Hypromelloses Magnesium Stearate Methacrylic Acid Polyethylene Glycol, Unspecified Silicon Dioxide Sodium Starch Glycolate Type A Potato Talc Titanium Dioxide Triethyl Citrate

Identifiers & Packaging

Pill Appearance
Imprint: 711 Shape: oval Color: red Size: 10 mm Score: 1
Marketing Status
ANDA Active Since 2017-06-19

Description

NDC 70771-1071-1 Mesalamine Delayed-release Tablets, 1.2 g Rx only 120 tablets


Medication Information

Description

NDC 70771-1071-1 Mesalamine Delayed-release Tablets, 1.2 g Rx only 120 tablets

Package Label.principal Display Panel

NDC 70771-1071-1

Mesalamine Delayed-release Tablets, 1.2 g

Rx only

120 tablets


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1071-1

Mesalamine Delayed-release Tablets, 1.2 g

Rx only

120 tablets


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)